慢性免疫介导性皮肤疾病的多种病理分析:SKINERGY协议和战略评估
N G Koster1,2,3, J M P A van den Reek4, E M G J de Jong4
1Division BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
概括
该SKINERGY研究分析了五种慢性炎症性皮肤疾病,以确定针对性治疗的生物标志物. 这项研究旨在改善现实世界临床环境中的疾病理解和治疗反应.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 生物标志物研究 生物标志物研究
背景情况:
- 下一代免疫皮肤病学 (NGID) 项目调查了五种慢性免疫媒介炎症性皮肤疾病:亚托皮炎 (AD),斑块性牛皮 (PSO),补充性水炎 (HS),慢性自发性疹 (CSU) 和皮肤性红斑狼 (CLE).
- 作为NGID的一部分,SKINERGY研究是一项多中心的,观察性的,纵向的篮子研究,将这些疾病与皮肤T细胞淋巴瘤 (mycosis fungoides) 和健康对照进行比较.
研究的目的:
- 与健康志愿者相比,评估疾病特征.
- 确定疾病分层的生物标志物,并在现实临床环境中预测治疗反应.
- 分析疾病之间的相似性/差异以及随着时间的推移而发生的变化,比较响应者和非响应者.
主要方法:
- 招募患有AD (120),PSO (160),HS (80),CSU (120) 和CLE (120) 的患者,与匹配的健康志愿者 (120) 和真菌菌菌菌群 (120) 作为对照.
- 使用综合性评估,包括取血样,皮肤活检,带剥离,拭子,多式成像,远程健康和患者报告的结果.
- 采用多主题分析,患者倡导小组为研究设计做出贡献,确保临床相关性.
主要成果:
- 创建一个准备用于机器学习的数据集,详细说明纵向生物标志物变化.
- 包括各种数据类型:组织学,代谢学,空间蛋白质组学,转录学,脂质组学,微生物组学,成像学,远程健康,PROM和临床参数.
结论:
- 预计SKINERGY研究中识别的生物标志物概况将指导针对性的治疗选择.
- 这些发现可能会提高临床实践中的向治疗疗效.
- 这项研究将加深对慢性免疫介导性皮肤疾病的疾病病理学的理解.
相关概念视频
Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Cell-mediated Immune Responses
84.1K
Overview
84.1K
Chronic Kidney Disease I: Introduction
740
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
What is the Immune System?
130.5K
Overview
130.5K
Cytotoxic T Cells-mediated Immune Response
7.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.5K


